NEW YORK, December 14 - Rosetta Inpharmatics inaugurated Thursday a new gene
expression profiling facility in Bothell, Wash.
At the facility, researchers will use image analysis technology and
molecular biology processes to generate gene expression data for drug and
drug target discovery, the company said.
" Our new facility in Bothell will help us further our efforts in gene
expression research, and will advance our goal to develop solutions that
will accelerate and enhance the drug discovery process," said Rosetta CEO